KLF5 and breast cancer: To assess the potential relevance of SRC-YAP1/KLF5 signaling axis with the BC patients, we further performed the TMA analysis using the YAP1 and KLF5 antibodies as we previously have done for analyzing SRC expression in patient BC tissues (Fig S1A).